Genomic Valley Biotech announced that the 31th Annual General Meeting(AGM) of the company will be held on 31 December 2025.Powered by Capital Market - Live News

Genomic Valley Biotech reported no net profit/loss in the quarter ended September 2025 as against net profit of Rs 0.15 crore during the previous quarter ended September 2024. Sales declined 57.14% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.090.21 -57 OPM %066.67 - PBDT00.15 -100 PBT00.15 -100 NP00.15 -100 Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 15 October 2025.Powered by Capital Market - Live News

Net profit of Genomic Valley Biotech declined 84.62% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.13 crore during the previous quarter ended June 2024. Sales declined 43.75% to Rs 0.09 crore in the quarter ended June 2025 as against Rs 0.16 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales0.090.16 -44 OPM %22.2281.25 - PBDT0.020.13 -85 PBT0.020.13 -85 NP0.020.13 -85 Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live News